FDA Clears First Neurostimulation Device for PTSD

Neurovalens’ Modius Spero has become the first FDA-approved neuromodulation device for treating PTSD symptoms. Veterans are set to gain access through the VA this summer.

The post FDA Clears First Neurostimulation Device for PTSD appeared first on MedCity News.

Leave a Reply

Your email address will not be published. Required fields are marked *